{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T09:17:48Z","timestamp":1707297468468},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7,1]]},"DOI":"10.1093\/jac\/dkm123","type":"journal-article","created":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T20:39:42Z","timestamp":1178311182000},"page":"162-165","source":"Crossref","is-referenced-by-count":31,"title":["Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection"],"prefix":"10.1093","volume":"60","author":[{"given":"Carolina","family":"Serena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Javier","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00e7al","family":"Marin\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Mar","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Guarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,5,4]]},"reference":[{"key":"key\n\t\t\t\t20171010150914_DKM123C1","volume-title":"Atlas of Clinical Fungi","author":"de Hoog","year":"2000","edition":"Second Edition"},{"key":"key\n\t\t\t\t20171010150914_DKM123C2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1469-0691.2001.tb00005.x","article-title":"Uncommon opportunistic fungi: new nosocomial threats","volume":"7","author":"Groll","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171010150914_DKM123C3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CMR.8.4.515","article-title":"Cryptococcosis in the era of AIDS\u2014100 years after the discovery of Cryptococcus neoformans","volume":"8","author":"Mitchell","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20171010150914_DKM123C4","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171010150914_DKM123C5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00019048-199507000-00019","article-title":"Decreased fluconazole susceptibility of a relapse Cryptococcus neoformans isolate after fluconazole treatment","volume":"4","author":"Currie","year":"1995","journal-title":"Infect Dis Clin Pract"},{"key":"key\n\t\t\t\t20171010150914_DKM123C6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/dkh361","article-title":"Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002","volume":"54","author":"Sar","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171010150914_DKM123C7","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/AAC.00163-06","article-title":"In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts","volume":"50","author":"Sabatelli","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171010150914_DKM123C8","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/AAC.48.6.2014-2020.2004","article-title":"Effects of voriconazole on Cryptococcus neoformans","volume":"48","author":"tan Duin","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171010150914_DKM123C9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/B:MYCO.0000041904.71381.e3","article-title":"Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure","volume":"158","author":"Sabbatani","year":"2004","journal-title":"Mycopathologia"},{"key":"key\n\t\t\t\t20171010150914_DKM123C10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171010150914_DKM123C11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/377131","article-title":"Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients","volume":"37","author":"Lutsar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171010150914_DKM123C12","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts\u2014Second Edition: Approved Standard M27-A2","author":"National Committee for Clinical Laboratory Standards","year":"2002"},{"key":"key\n\t\t\t\t20171010150914_DKM123C13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/jac\/dkg261","article-title":"Improving the mouse model for studying the efficacy of voriconazole","volume":"51","author":"Graybill","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171010150914_DKM123C14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11046-006-0039-4","article-title":"Efficacy of voriconazole in experimental Cryptococcus neoformans infection","volume":"162","author":"Mavrogiorgios","year":"2006","journal-title":"Mycopathologia"},{"key":"key\n\t\t\t\t20171010150914_DKM123C15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/AAC.45.2.601-604.2001","article-title":"Efficacy of voriconazole in treatment of murine pulmonary blastomycosis","volume":"45","author":"Sugar","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171010150914_DKM123C16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1124\/dmd.31.6.731","article-title":"The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human","volume":"31","author":"Roffey","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"key\n\t\t\t\t20171010150914_DKM123C17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijantimicag.2006.01.003","article-title":"Clinical pharmacokinetics of voriconazole","volume":"27","author":"Lev\u00eaque","year":"2006","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/60\/1\/162\/2170031\/dkm123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T14:38:29Z","timestamp":1556375909000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/60\/1\/162\/729162\/Efficacy-of-voriconazole-in-a-murine-model-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,4]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007,5,4]]},"published-print":{"date-parts":[[2007,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkm123","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,7]]},"published":{"date-parts":[[2007,5,4]]}}}